FAQ

The MAP study is a three-phased research project endeavouring to map current ADHD service provision in England and then co-create evidence-based guidance to improve and better co-ordinate primary care for young people aged 16-25 with ADHD.

The MAP study has three phases:

1. The survey phase – A national survey of primary care practitioners, as well as organisations providing and funding ADHD services. This is to map current care pathways, learn about practitioner roles and prescribing practices, and identify underserved areas.
2. The interview phase – Interviews with 10-15 young people with ADHD exploring experiences, information needs, and expectations of primary care management of ADHD. This is alongside focus groups with 10-15 practitioners and linked organisations, to consider the information and support they need in their roles managing and caring for young people with ADHD.
3. The workshop phase – Building on findings from phases 1 and 2, workshops with practitioners, linked organisations, and YP with ADHD, will co-produce key messages for improving primary care support. Workshops with key stakeholders, such as NHS Digital, will develop a blueprint for technology-supported solutions, and identify any barriers to implementation. 

This 27-month study is due to complete in July 2024.

This study is funded by the National Institute for Health and Care Research (NIHR) and has been approved by the Health Research Authority (HRA) and Health and Care Research Wales (HCRW). Approval was issued by the Yorkshire & The Humber – Bradford Leeds Research Ethics Committee (REC) (Reference: 22/YH/0132) on 14th July 2022.

ClinicalTrials.gov registration number: NCT05518435

The MAP study is funded by a National Institute for Health and Care Research (NIHR) Three Research Schools’ Mental Health Research Fellowship. Located within the Exeter NIHR School for Primary Care Research (SPCR).

Grant Reference Number MHF008